Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03953976 · ClinicalTrials.gov registry record · Phase 2
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT03953976 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 67 participants.
The verdict
NCT03953976, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
Elective nodal irradiation has been a longstanding standard-of-care in the management of mucosal squamous cell carcinoma of the head and neck. Recent studies have suggested that reduced elective dose and volume may be a viable approach to improve toxicity. In this study, we are eliminating the elective neck treatment, focusing therapy on involved and suspicious nodes.
Interventions
- RADIATION Intensity modulated radiation therapy (IMRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-07-23 |
| Est. Completion | 2024-01-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03953976
The ClinicalTrials.gov registry entry for NCT03953976 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensity modulated radiation therapy (IMRT) is the first listed.
NCT03953976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03953976 about?
NCT03953976 is a clinical study titled "INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy". Elective nodal irradiation has been a longstanding standard-of-care in the management of mucosal squamous cell carcinoma of the head and neck. Recent studies have suggested that reduced elective dose and volume may be a viable approach to improve toxicity. In this study, we are eliminating the elect...
What is the current status of trial NCT03953976?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2019-07-23. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT03953976?
The interventions under investigation include: Intensity modulated radiation therapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT03953976?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.